SARS-CoV-2 infection in a patient with destination left ventricular assist device
- Journal of Lung, Pulmonary & Respiratory Research
Guillermo Careaga-Reyna MD,1 Hugo Jesus Zetina-Tun2
PDF Full Text
Recipients of LVAD for destination therapy may represent a challenge in the treatment of COVID-19. We present a case of a 58 year-old male with LVAD support complicated with SARS-CoV-2 who declines for hospital admission despite interstitial pneumonia and lower O2 saturation. The patient recieved ambulatory support and treatment with anticoagulation, supplementary O2 , steroids, antibiotics, ivermectin with succesful evolution and recovery.
COVID-19, SARS-CoV-2, LVAD, heart failure